Since the 1970s, nociceptive reflexes have been used in pain research and also increasingly in clinical pain therapy in recent years. The most researched reflex in this area is the nociceptive flexion reflex of the lower limb (RIII-Reflex) which is characterised by the withdrawal movement of the upper leg after a painful stimulus is applied to the foot.
Pain reflexes such as this flexion reflex are involuntary reflex responses that cannot be controlled by the patient and are elicited using a specific stimulus. The extent of the reflex response correlates to the painfulness of the stimulus.
Therefore, the pain reflex can be used to provide information about the painfulness of the stimulus without having to factor in the subjective evaluation of the patient.
Because pathological pain or pain medications directly affect the magnitude of the reflex, such reflexes can be used to provide an objective and patient-independent quantification of pain or the effect of pain medications.
Because the pain reflex can be determined without the conscious involvement of the patient, reflex measurement also provides information about the processing of pain by non-communicative patients, for example, those who are sedated.
The founders of Dolosys GmbH have developed a technique, for which they have also applied for a patent, to automatically determine such pain reflexes continuously and over a longer period.
The reflexes measured in this way are automatically evaluated and translated into direct and transparent treatment recommendations for the patient to optimise individual analgesia.
The technique can be used in a number of different areas in pain research and clinical pain therapy:
Determining individual analgesic effect for chronic pain patients, independent of the subjective evaluation by the patient
Testing the individual time course of action of analgesics for chronic pain patients
Quantifying the effect and determining the time courses of the effects of analgesics in the clinical testing of analgesics
Ensuring continuous analgesia monitoring for non-communicative patients, for example, those under sedation in intensive care units
This technology based on the automatic determination of pain reflexes differs from other technologies for measuring analgesia thanks to a range of special features:
Objective and patient-independent quantification of pain control (analgesia) even for non-communicative patients
More precise and better pain specificity compared to other methods
Analgesia can be determined not only at isolated time points but continuously over a longer period
Wide measurement range from analgesic underdosing to analgesic overdosing
Automatic translation of the information obtained from the reflexes into direct and transparent treatment recommendations to optimise the analgesia